Welcome to our dedicated page for AEHR TEST SYSTEMS SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AEHR TEST SYSTEMS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AEHR TEST SYSTEMS's regulatory disclosures and financial reporting.
Howard T. Slayen, a director of Aehr Test Systems, sold 20,000 shares of common stock on 2026-08-04 at an average price of $108.2961 per share in a sale classified as an open-market or private transaction. Following the sale, he directly holds 146,367 shares, which include shares subject to unvested restricted stock units.
Aehr Test Systems director Laura Oliphant donated 500 shares of common stock on August 4, 2026 as a bona fide gift to USA Triathlon Foundation. The transaction carried a reported per-share price of $0.0000, so no sale proceeds were received. Following the donation, she directly owns 17,817 shares, which include shares subject to unvested restricted stock units.
A shareholder of AEHR Test Systems filed a notice of proposed sale of common stock. The filing lists 2,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with a reported value of $201,916.91.
The notice also identifies underlying sources of these shares as restricted stock awards, including 235 shares scheduled to vest on April 27, 2026 and 1,765 shares scheduled to vest on July 1, 2026, both described as compensation.
EVP Alberto Salamone of Aehr Test Systems reported that 204 shares of Common Stock were withheld on August 3, 2026 at $79.98 per share to satisfy tax withholding obligations upon vesting of restricted stock units. This was not an open-market sale. Following the withholding, he holds 51,634 shares, including shares subject to unvested restricted stock units.
AEHR Test Systems director Howard T. Slayen reported a bona fide gift of 5,000 shares of Common Stock on 2026-07-30. The shares were gifted to the Everett Drake Slayen Trust. Following this transfer, he directly holds 166,367 shares, which include shares subject to unvested restricted stock units.
Jane Street Group, LLC and its subsidiaries reported a passive ownership stake in AEHR TEST SYSTEMS common stock. The filing states that Jane Street Group, LLC beneficially owns 1,648,523 shares of AEHR common stock, representing 5.1% of the class.
All of these shares are reported with shared voting and shared dispositive power, and no shares are held with sole voting or dispositive power. Subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC, each organized in Delaware, are identified as the entities through which the securities were acquired. The reporting persons list their principal business address at 250 Vesey Street, 3rd Floor, New York, NY 10281.
Aehr Test Systems President and CEO Gayn Erickson reported a tax-related share withholding. On 2026-07-27, 1057.0000 common shares were withheld at $77.4800 per share to satisfy tax obligations on vesting equity awards, and the disclosure states this did not represent a sale by Erickson. After this, he held 197521.0000 shares directly, including unvested awards, and 197723.0000 shares indirectly through a trust.
Aehr Test Systems executive Vernon Rogers, Exec VP of Sales & Mktg., reported a tax-related share withholding on July 27, 2026. 198 shares of common stock were withheld at $77.48 per share to satisfy tax obligations upon vesting of restricted stock units, which the company notes does not represent a sale. After this transaction, Rogers directly holds 192,226 shares, and this amount includes shares subject to unvested restricted stock units.
Aehr Test Systems officer Alistair N. Sporck reported that 133 shares of common stock were withheld at $77.48 per share to satisfy tax withholding obligations upon vesting of restricted stock units; this was not an open‑market sale. After the withholding, he held 25,547 shares directly, including unvested RSUs, and 5,177 shares indirectly through a trust.